Webdisclosure.com

SANOFI-AVENTIS (EPA:SAN)

18/04/2021 15:10

20-F

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

09/04/2021 06:01

Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi’s novel investigational IL-2

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

31/03/2021 23:15

FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

31/03/2021 16:05

Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

22/02/2021 19:00

FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of =50%

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

09/02/2021 23:15

FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

17/12/2020 22:30

Availability of the Q4 2020 Memorandum for modelling purposes

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

30/11/2020 22:37

Sanofi: Information concerning the total number of voting rights and shares - October 2020

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

30/11/2020 22:15

Sanofi: Disclosure of trading in own shares

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

23/11/2020 22:08

Sanofi: Disclosure of trading in own shares

Voir tous les communiqués de SANOFI-AVENTIS

«
5
6
7
8
9
10
11
12
13
14
15